| [1] |
LI Qinghua, ZHAO Yan, ZHAO Haigang, GAO Pengfei, XU Bingxin.
Value of ABCB1 G2677T gene polymorphism detection in lipid-lowering therapy with atorvastatin in patients suffered from ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 633-640.
|
| [2] |
QIN Wenxiu, XU Junfeng, YANG Ting, WANG Pingfei.
Research progress on signaling pathway of tanshinoneIIA in treatment of nerve injury after ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 705-713.
|
| [3] |
WU Zhiyong, LIU Bingrong, LI Bin, TANG Rui.
Value of red blood cell distribution width in predicting early poor neurologic improvement after intravenous thrombolysis in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 307-314.
|
| [4] |
FU Hong, TIAN Lei.
Individualized precision therapy for patients with ischemic stroke and hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 870-876.
|
| [5] |
LIANG Meifang, CHEN Qingzhuang, YANG Peiqun, WANG Yong.
Efficacy and safety of generic and branded atorvastatin in patients with ischemic stroke/transient ischemic attack: A real-world study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 785-792.
|
| [6] |
HUANG Yaqin, XUE Rong.
Treatment of sleep disorder in patients with acute cerebrovascular disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 516-521.
|
| [7] |
XIA Chunyong, ZHANG Zuowen, HE Xiaoyan, LIU Jie, LI Xiaoya, CHANG Qiuhong, QIN Lijuan, CAO Zhenming, DING Ling.
Correlation between CYP2C19 gene polymorphism and individualized medication in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 318-323.
|
| [8] |
WU Mengyao, ZHAO Hongqing, WANG Yuhong.
Advances of the ion channels related to depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 949-954.
|
| [9] |
CHEN Yanbin, DENG Shanshan.
Effect of Xingnaojing injection on the expression of hypoxia-inducible factor-1α in patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 821-824.
|
| [10] |
SHEN Chen, LI Yunman, XIA Nian, XU Dan, HAN Dan, CHEN Shijie.
Research on the inhibition of Treg cells on MMP-9 in rheumatoid arthritis with acute cerebral ischemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 831-840.
|
| [11] |
MA Honggang，PAN Qinmei，ZHU Feifei，WANG Yaxian，WANG Zhuang.
Relationship between leukotriene B4，carotid plaque and progressive ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 689-693.
|
| [12] |
CHEN Tao, YAN Yongxing, SHEN Yonghui.
Application of serum B type natriuretic peptide precursor and blood pressure variability in patients with non-cardiogenic ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 570-573.
|
| [13] |
WANG Qinghua, CHU Zhaohu, XU Yesong, ZHAO Shoucai, FANG Fang, SUN Aiping.
Treatment efficacy of scalp acupuncture on the score of MoCA and serum of Hcy in stroke patients with obstacles cognitive
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 165-169.
|
| [14] |
ZHANG Feng-yun, ZHAO Yan, WU Yu-lin.
Effect of protein kinase C on cerebral ischemic reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(4): 461-468.
|
| [15] |
XIONG Fang-ling, GAO Yi-lu.
Research progress of pharmacotherapy on delayed cerebral vasospasm after subarachnoid hemorrhage
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(8): 955-960.
|
